Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01901887 · ClinicalTrials.gov registry record · Phase 1

The Better Resiliency Among Veterans With Omega-3's (BRAVO) Study

A Phase 1 study, sponsored by Medical University of South Carolina.

Terminated
Registry status
Phase 1
Development phase
125
Enrollment target

NCT01901887 is a Phase 1 study that was terminated before completion, run by Medical University of South Carolina. The registered enrollment target is 125 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01901887, a Phase 1 study, was terminated before completion, sponsored by Medical University of South Carolina.

TERMINATED
Registry status
Phase 1
Development phase
125 participants
Enrollment target

Study Summary

The BRAVO study seeks to determine if dietary supplementation with omega-3 highly unsaturated fatty acids (omega-3 HUFAs) reduces the risk for serious suicidal behaviors, suicidal thinking, negative emotions, and symptoms associated with suicide risk, in a Veteran and non-Veteran population that is at risk for suicidal behaviors. This study seeks to evaluate the efficacy of omega-3 HUFAs among a representative population of US Veterans and non-Veterans already receiving appropriate medical care so that if successful, these results can be readily applied to broader populations in the US.

Interventions

  • DRUG Study Juice
  • DRUG Placebo Juice

Trial Details

FieldValue
Enrollment Target 125 participants
Start Date 2014-03-01
Est. Completion 2016-08-30
Phase Phase 1

What the Registry Record Tells You About NCT01901887

The ClinicalTrials.gov registry entry for NCT01901887 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 125 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Study Juice is the first listed.

NCT01901887 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01901887 about?

NCT01901887 is a clinical study titled "The Better Resiliency Among Veterans With Omega-3's (BRAVO) Study". The BRAVO study seeks to determine if dietary supplementation with omega-3 highly unsaturated fatty acids (omega-3 HUFAs) reduces the risk for serious suicidal behaviors, suicidal thinking, negative emotions, and symptoms associated with suicide risk, in a Veteran and non-Veteran population that is ...

What is the current status of trial NCT01901887?

This trial is currently terminated. It is a Phase 1 study. The enrollment target is 125 participants. The study started on 2014-03-01. Estimated completion is 2016-08-30.

What interventions are being tested in trial NCT01901887?

The interventions under investigation include: Study Juice (DRUG), Placebo Juice (DRUG).

Who is sponsoring clinical trial NCT01901887?

This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.